Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 111.00 INR
Change Today +0.25 / 0.23%
Volume 706.0
CFIN On Other Exchanges
Symbol
Exchange
CFIN is not on other exchanges.
As of 11:37 PM 07/30/15 All times are local (Market data is delayed by at least 15 minutes).

camlin fine sciences ltd (CFIN) Snapshot

Open
111.00
Previous Close
110.75
Day High
111.00
Day Low
111.00
52 Week High
06/29/15 - 129.00
52 Week Low
08/1/14 - 45.50
Market Cap
10.6B
Average Volume 10 Days
1.3M
EPS TTM
5.77
Shares Outstanding
95.9M
EX-Date
07/27/15
P/E TM
19.2x
Dividend
0.45
Dividend Yield
0.41%
Current Stock Chart for CAMLIN FINE SCIENCES LTD (CFIN)

Related News

No related news articles were found.

camlin fine sciences ltd (CFIN) Related Businessweek News

No Related Businessweek News Found

camlin fine sciences ltd (CFIN) Details

Camlin Fine Sciences Limited manufactures and exports bulk drugs, fine chemicals, and food grade products in India and internationally. The company offers food ingredients, which primarily includes antox tert-butyl hydroquinone; antox butylated hydroxyanisole; and antox ascorbyl palmitate. It also provides industrial products consisting of guaiacol, an intermediate for manufacturing Vanillin; veratrole, an intermediate for the pharmaceutical and agrochemical industry; and tertiary butyl catechol and hydroquinone mono methyl ether, which are polymerization inhibitors for use in the petrochemical industry. The company was formerly known as Camlin Fine Chemicals Limited and changed its name to Camlin Fine Sciences Limited in August 2011. Camlin Fine Sciences Limited was incorporated in 1993 and is based in Mumbai, India.

Founded in 1993

camlin fine sciences ltd (CFIN) Top Compensated Officers

Managing Director, Director, Member of Stakeh...
Total Annual Compensation: 7.5M
Chief Financial Officer and Executive Directo...
Total Annual Compensation: 1.9M
Executive Director
Total Annual Compensation: 4.0M
Compensation as of Fiscal Year 2015.

camlin fine sciences ltd (CFIN) Key Developments

Camlin Fine Sciences Ltd. Reports Audited Standalone Earnings Results for the Fourth Quarter and Year and Consolidated Earnings Results for the Year Ended March 31, 2015

Camlin Fine Sciences Ltd. reported audited standalone earnings results for the fourth quarter and year and consolidated earnings results for the year ended March 31, 2015. For the quarter, on standalone basis, the company reported total income from operations of INR 1,351.231 million compared to INR 1,105.987 million, profit from operations before other income, interest and exceptional items of INR 142.104 million compared to INR 126.678 million, profit from ordinary activities before tax of INR 87.177 million compared to INR 70.565 million and net profit of INR 84.189 million or INR 0.88 per diluted share compared to INR 34.018 million or INR 0.36 per diluted share for the last year. For the year, on standalone basis, the company reported total income from operations of INR 4,306.993 million compared to INR 3,743.927 million, profit from operations before other income, interest and exceptional items of INR 509.75 million compared to INR 492.741 million, profit from ordinary activities before tax of INR 317.703 million compared to INR 292.058 million and net profit of INR 258.176 million or INR 2.70 per diluted share compared to INR 189.686 million or INR 2.01 per diluted share for the last year. For the year, on consolidated basis, the company reported total income from operations of INR 5,677.269 million compared to INR 5,170.287 million, profit from operations before other income, interest and exceptional items of INR 679.266 million compared to INR 498.59 million, profit from ordinary activities before tax of INR 528.335 million compared to INR 348.638 million and net profit of INR 550.414 million or INR 5.77 per diluted share compared to INR 287.377 million or INR 3.04 per diluted share for the last year.

Camlin Fine Sciences Ltd Approves Setting Up Subsidiaries in Gujarat, Mexico and China

Camlin Fine Sciences Ltd. announced that the Board of Directors of the company at its meeting held on May 12, 2015, has approved the setting up a wholly owned subsidiary company in Mexico for undertaking trading and distribution of Antioxidants, food ingredients, Blends, Formulations, feeds, performance chemicals in Central American markets and setting up a wholly owned subsidiary company in China for undertaking trading and distribution of Antioxidants, food ingredients, Blends, Formulations, feeds, performance chemicals in Chinese markets and acquisition of land admeasuring 64,407.91 square meters and setting up a manufacturing facility for Hydroquinone/Catechol and its down steam products Guaiacol and Vanillin at Dahej Sez, Bharuch District, Gujarat.

Camlin Fine Sciences Ltd Recommends a Dividend for the Year 2014-2015

Camlin Fine Sciences Ltd. announced that the board of directors of the company at its meeting held on May 12, 2015, has recommended a dividend at rate of 45% (INR 0.45 per share) for the year 2014-2015, which would be paid subject to the shareholders approval.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CFIN:IN 111.00 INR +0.25

CFIN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Borregaard ASA 51.75 NOK -0.25
DIC Corp ¥293.00 JPY +1.00
Eastman Chemical Co $78.59 USD +0.51
Mitsui Chemicals Inc ¥471.00 JPY +7.00
Ube Industries Ltd ¥216.00 JPY -1.00
View Industry Companies
 

Industry Analysis

CFIN

Industry Average

Valuation CFIN Industry Range
Price/Earnings 18.8x
Price/Sales 1.8x
Price/Book 7.7x
Price/Cash Flow 14.5x
TEV/Sales 1.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CAMLIN FINE SCIENCES LTD, please visit www.camlinfs.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.